Principles and Framework for the Operationalisation of Meaningful Human Control Over Autonomous Systems. [PDF]
Calvert SC.
europepmc +1 more source
Enhancements for distributed certificate authority approaches for mobile wireless ad hoc networks.
Brian Van Leeuwen +2 more
openalex +2 more sources
INF2‐Related Charcot–Marie–Tooth Disease in a Japanese Cohort: Genetic and Clinical Insights
ABSTRACT Background INF2 mutations cause focal segmental glomerulosclerosis (FSGS) and Charcot–Marie–Tooth disease (CMT). Accurate genetic diagnosis is critical, as INF2‐related FSGS is typically resistant to immunotherapy yet rarely recurs after transplantation, and its associated neuropathy can mimic treatable immune‐mediated disorders such as ...
Chikashi Yano +27 more
wiley +1 more source
The U.S. Food Safety Modernization Act: Implications in Transnational Governance of Food Safety, Food System Sustainability, and the Tension with Free Trade [PDF]
Fortin, Neal
core +1 more source
Certificate Authority Collapse: Regulating Systemic Vulnerabilities in the HTTPS Value Chain
Axel Arnbak, N.A.N.M. van Eijk
openalex +1 more source
Expanding Hereditary Spastic Paraplegias Limits: Biallelic SPAST Variants in Cerebral Palsy Mimics
ABSTRACT Objective Hereditary spastic paraplegias (HSP) are rare neurodegenerative disorders marked by spasticity and lower limb weakness. The most common type, SPG4, is usually autosomal dominant and caused by SPAST gene variants, typically presenting as pure HSP.
Gregorio A. Nolasco +18 more
wiley +1 more source
Health laboratory licensing: a policy and best-practice analysis. [PDF]
Huber M +3 more
europepmc +1 more source
Arlington Fire District and Arlington Professional Firefighters Association, International Association of Fire Fighters (IAFF), AFL-CIO, Local 2393 (2006) [PDF]
core +1 more source
TIME FOR TEACHING TO ESTABLISH ITS OWN PROFESSIONAL CERTIFICATION AUTHORITY
Lawrence Ingvarson
openalex +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini +13 more
wiley +1 more source

